Waltham, MA-based Thermo Fisher Scientific has struck a deal to acquire Fermentas International for $260 million in cash, Thermo reports today. Fermentas, based in Burlington, Ontario, makes and sells life sciences research materials such as enzymes and reagents as well as diagnostic tools. The firm, which has 500 employees, had 2009 revenue of $54 million. Thermo (NYSE:[[ticker:TMO]]) says that Fermentas is expected to become part of its analytical technologies segment.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
